Disabled patients face discrimination from doctors. More than three decades after the passage of the Americans with Disabilities Act (ADA), some doctors still harbor biases toward people with disabilities, and even actively avoid accepting them as patients, a new study finds. Read more
TUESDAY, Oct. 4, 2022 (HealthDay News) -- Football Hall of Famer Terry Bradshaw revealed Sunday that he has been treated for two different types of cancer in the past year.
MONDAY, Oct. 3, 2022 (HealthDay News) -- For early-stage invasive breast cancer, involved or close pathological margins after breast-conserving surgery are associated with an increased risk for distant and local recurrence, according to a review published online Sept. 21 in The BMJ.
MONDAY, Oct. 3, 2022 (HealthDay News) -- New research confirms that COVID-19 can be life-threatening for certain cancer patients: More than 16,500 Americans with cancer died from complications related to coronavirus infection during the first 10 months of the pandemic.
FRIDAY, Sept. 30, 2022 (HealthDay News) -- More than 60 percent of young women diagnosed with cancer have sexual dysfunction, with more problems reported by women with cancer than among women from the general population, according to a study published online Sept. 30 in Acta Oncologica.
THURSDAY, Sept. 29, 2022 (HealthDay News) -- From March to December 2020, more than 16,500 deaths occurred in cancer patients with complications of COVID-19, according to a research letter published online Sept. 29 in JAMA Oncology.
Katie Couric said Wednesday that she'd been diagnosed with breast cancer and underwent surgery and radiation treatment this summer to treat the tumor. Get more trending news here.
Katie Couric, who underwent colon cancer screening on the "Today" show in 2000, says she was diagnosed with breast cancer on the first day of summer.
WEDNESDAY, Sept. 28, 2022 (HealthDay News) -- How long can someone newly diagnosed with dementia expect to live?
MONDAY, Sept. 26, 2022 (HealthDay News) -- Triplet therapy of cabozantinib + nivolumab + ipilimumab significantly improves progression-free survival (PFS) compared with placebo + nivolumab + ipilimumab for patients with previously untreated advanced renal cell carcinoma (aRCC) of intermediate or poor risk, according to a study presented at the annual meeting of the European Society for Medical Oncology, held from Sept. 9 to 13 in Paris.
CEDAR FALLS — A deejay for 93.5 FM The Mix is holding a radiothon Thursday to raise money for a Cedar Valley breast cancer support group.
MONDAY, Sept. 26, 2022 (HealthDay News) -- Low-income cancer survivors have increased odds of fair/poor health, and reduced odds of having health insurance coverage, according to a study published online Sept. 6 in JCO Oncology Practice.
MONDAY, Sept. 26, 2022 (HealthDay News) -- Here's another reason to stay out of jail: New research shows the risk of dying from cancer is sharply higher among those who are behind bars or have been recently released.
Three North Scott families reflect on their journeys with childhood cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) -- Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 in JAMA Oncology.
WEDNESDAY, Sept. 21, 2022 (HealthDay News) -- Considerable progress has been made to improve, extend, and save lives of patients with cancer in the last year, according to the 12th annual Cancer Progress Report released by the American Association for Cancer Research (AACR).
MONDAY, Sept. 19, 2022 (HealthDay News) -- Sugar-sweetened beverage (SSB) consumption is associated with increased mortality from specific cancers, according to a study published online Sept. 15 in Cancer Epidemiology, Biomarkers & Prevention.
MONDAY, Sept. 19, 2022 (HealthDay News) -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published in the September-October issue of Practical Radiation Oncology, recommendations are presented for the use of radiation therapy (RT) in patients with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse glioma.
FRIDAY, Sept. 16, 2022 (HealthDay News) -- For women with breast cancer, their race may help predict the success of hormone therapy given before surgery.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- Among patients with local regionally advanced oral cavity squamous cell carcinoma, rates of postoperative adverse events appear to be similar for those receiving neoadjuvant pembrolizumab or standard-of-care treatment, according to a study published online Aug. 25 in JAMA Otolaryngology-Head & Neck Surgery.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 in Hematological Oncology.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- For patients with borderline resectable/locally advanced (BR/LA) pancreatic ductal adenocarcinoma (PDAC), preoperative fluorodeoxyglucose positron emission tomography (FDG-PET) may predict pathologic response to neoadjuvant therapy (NAT), according to a study published online Sept. 8 in the Journal of the National Comprehensive Cancer Network.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- Oxygen deprivation resulting from obstructive sleep apnea (OSA) is associated with cancer, according to a study presented at the European Respiratory Society International Congress 2022, held from Sept. 4 to 6 in Barcelona, Spain.